Search

Your search keyword '"Gaulard, Philippe"' showing total 1,513 results

Search Constraints

Start Over You searched for: Author "Gaulard, Philippe" Remove constraint Author: "Gaulard, Philippe"
1,513 results on '"Gaulard, Philippe"'

Search Results

1. Modeling NK-cell lymphoma in mice reveals its cell-of-origin and microenvironmental changes and identifies therapeutic targets

2. Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas

3. Dependence on mitochondrial respiration of malignant T cells reveals a new therapeutic target for angioimmunoblastic T-cell lymphoma

5. Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma)

7. MYC Rearrangement Prediction From LYSA Whole Slide Images in Large B-Cell Lymphoma: A Multicentric Validation of Self-supervised Deep Learning Models

8. Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study

10. Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5′RACE

12. High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma

13. Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group

17. Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations

18. Lymph node excisions provide more precise lymphoma diagnoses than core biopsies: a French Lymphopath network survey

19. KIR3DL2 contributes to the typing of acute adult T-cell leukemia and is a potential therapeutic target

20. Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV

21. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

22. Overcoming IMiD resistance in T-cell lymphomas through potent degradation of ZFP91 and IKZF1

24. Comprehensive genetic profiling reveals frequent alterations of driver genes on the X chromosome in extranodal NK/T-cell lymphoma

28. Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma

29. ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells

30. Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial

31. Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatment

32. Clinical and histological study of follicular helper T-cell lymphomas with indolent evolution

33. Super-enhancer-based identification of a BATF3/IL-2R−module reveals vulnerabilities in anaplastic large cell lymphoma

35. Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry

38. Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology.

39. Angioimmunoblastic T‐cell lymphoma and Kaposi sarcoma: A fortuitous collision?

40. KIR3DL2 also represents a novel therapeutic target in non-cutaneous aggressive systemic peripheral T-cell lymphomas

42. Tumor necrosis factor receptor type 2 (TNFR2) may represent an alternative therapeutic target in Sézary syndrome and mycosis fungoides

45. Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation

46. Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas

47. The Mutator Pathway Is a Feature of Immunodeficiency-Related Lymphomas

48. S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA

50. S238: CLONAL ARCHITECTURE OF RELAPSED OR REFRACTORY ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA: AN ANCILLARY STUDY OF THE ORACLE TRIAL, A LYSA STUDY

Catalog

Books, media, physical & digital resources